Key result
Calibrated-IBS value of carotid plaque was independently associated with future cardiovascular events in asymptomatic type 2 diabetic patients.
Why the study?
Does ultrasonic tissue characterization of carotid plaque using integrated backscatter analysis improve the prediction of cardiovascular events in asymptomatic type 2 diabetic patients?
Cohort (n=85)
Does ultrasonic tissue characterization of carotid plaque using integrated backscatter analysis improve the prediction of cardiovascular events in asymptomatic type 2 diabetic patients?
Calibrated-IBS value of carotid plaque improves the prediction of cardiovascular events in asymptomatic type 2 diabetic patients beyond conventional risk factors.
Answers are grounded in this paper and cite their sources.
May enhance CV risk prediction in asymptomatic T2D; hypothesis-generating and requires prospective validation.
OBJECTIVE: The aim of this study is to evaluate whether noninvasive ultrasonic tissue characterization of carotid plaque using integrated backscatter (IBS) analysis can be a predictor of future cardiovascular events (CVE) in asymptomatic type 2 diabetic patients. RESEARCH DESIGN AND METHODS: We prospectively evaluated the association between Calibrated-IBS value, an ultrasonic marker for tissue characteristics of carotid plaque, and CVE in 85 asymptomatic type 2 diabetic patients with carotid plaque. RESULTS: The median follow-up period was 7.9 years, and there were 20 new CVE. The risk of CVE was significantly higher in the subjects with low Calibrated-IBS values (<-17.1 dB; n = 42) as compared with those with high values (≥-17.1 dB; n = 43) (P = 0.004, log-rank test). Cox proportional hazards regression analysis revealed that both Calibrated-IBS value (hazard ratio [HR] 0.802 [95% CI 0.710-0.906]; P < 0.0001) and plaque thickness (1.938 [1.170-3.213]; P = 0.010) were independently associated with CVE, even after adjustment for the 10-year risk for a general cardiovascular disease estimated by Framingham risk scoring (FRS). Time-dependent receiver operating characteristic curve analysis for CVE at 10 years after the baseline examinations revealed that area under the curve for Calibrated-IBS was 0.76 (0.60-0.90) and substantially higher than those for plaque thickness (0.60 [0.45-0.79]) and FRS (0.60 [0.40-0.78]). These analyses also revealed that the addition of both plaque thickness and Calibrated-IBS value to conventional risk factors significantly improved the event prediction. CONCLUSIONS: Calibrated-IBS value could improve the risk prediction of CVE in asymptomatic type 2 diabetic patients with carotid plaque.
No takes yet. Share an insight, caveat, or question.
Katakami et al. (2012) conducted a cohort in Asymptomatic type 2 diabetes with carotid plaque (n=85). Calibrated-IBS value vs. High Calibrated-IBS values (≥-17.1 dB) was evaluated on Cardiovascular events (CVE) (HR 0.802, 95% CI 0.710-0.906, p=< 0.0001). Calibrated-IBS value of carotid plaque was independently associated with future cardiovascular events in asymptomatic type 2 diabetic patients.
Synapse has enriched 10 related papers. Consider them for comparative context: